Expertise in
12
conditions

Dr. Jerry Molitor

Rheumatology
U Of M Health Clinics And Surgery Center Inc.
909 Fulton St SE, 
Minneapolis, MN 
Expertise in
12
conditions
U Of M Health Clinics And Surgery Center Inc.
909 Fulton St SE, 
Minneapolis, MN 

Overview

Jerry Molitor is a Rheumatologist in Minneapolis, Minnesota. Dr. Molitor is highly rated in 12 conditions, according to our data. His top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Scleroma, and Dermatomyositis.

His clinical research consists of co-authoring 32 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Rheumatology

Licenses

Internal Medicine in WA

Hospital Affiliations

M Health Fairview University Of Mn
M Health Fairview Southdale Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avera Health
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Sanford
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

U of M Health Clinics and Surgery Center Inc.
909 Fulton St SE, Minneapolis, MN 55455
Other Locations
M. Health Fairview Clinics and Surgery Maple Grove
14500 99th Ave N, Maple Grove, MN 55369

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: June 12, 2025
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 2
Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)
Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)
Enrollment Status: Completed
Publish Date: May 17, 2024
Intervention Type: Biological
Study Drug: Brentuximab vedotin
Study Phase: Phase 1/Phase 2
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: August 30, 2023
Intervention Type: Drug
Study Drug: Belumosudil (KD025)
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Other, Biological, Drug, Diagnostic test
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug
Study Drug: Lenabasum
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Enrollment Status: Completed
Publish Date: February 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

32 Total Publications

Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis.
Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis.
Journal: The Journal of rheumatology
Published: November 15, 2025
Similar Doctors
John Schousboe
Expertise in
3
conditions
Dr. John Schousboe
Rheumatology
Expertise in
3
conditions
Dr. John Schousboe
Rheumatology

Office

3800 Park Nicollet Blvd, 
Minneapolis, MN 
 (6.4 miles away)
952-993-3280
Languages Spoken:
English
See accepted insurances

John Schousboe is a Rheumatologist in Minneapolis, Minnesota. Dr. Schousboe is highly rated in 3 conditions, according to our data. His top areas of expertise are Osteoporosis, Fractured Spine, Postmenopausal Osteoporosis, Osteotomy, and Hip Replacement.

Expertise in
4
conditions
Dr. Barbara Segal
Rheumatology
Expertise in
4
conditions
Dr. Barbara Segal
Rheumatology

University Of Minnesota Masonic Children's Hospital

420 Delaware St SE, 
Minneapolis, MN 
 (0.4 miles away)
612-625-8690
Languages Spoken:
English
See accepted insurances

Barbara Segal is a Rheumatologist in Minneapolis, Minnesota. Dr. Segal is highly rated in 4 conditions, according to our data. Her top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Triple X Syndrome, and Arthritis.

Expertise in
23
conditions
Dr. Waseem N. Khan
Rheumatology
Expertise in
23
conditions
Dr. Waseem N. Khan
Rheumatology

Healtheast Medical Research Institute

1875 Woodwinds Dr, 
Woodbury, MN 
 (12.6 miles away)
651-232-6800
Languages Spoken:
English, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Waseem Khan is a Rheumatologist in Woodbury, Minnesota. Dr. Khan is highly rated in 23 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Psoriasis, Psoriatic Arthritis, and Systemic Sclerosis (SSc). Dr. Khan is currently accepting new patients.

Frequently Asked Questions about Dr. Jerry Molitor

How do I make an appointment with Dr. Jerry Molitor?

You can book an appointment with Dr. Jerry Molitor by calling their office at 612-626-6100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jerry Molitor a top-rated expert for Systemic Sclerosis (SSc)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jerry Molitor is classified as an Elite expert for Systemic Sclerosis (SSc), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jerry Molitor specialize in?

While Dr. Jerry Molitor is a Rheumatology, they have specific expertise in Systemic Sclerosis (SSc), Scleroderma, and Scleroma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Jerry Molitor participate in research or clinical trials?

Yes. Dr. Jerry Molitor has published 32 articles and abstracts on conditions like Systemic Sclerosis (SSc). You can view a list of Dr. Jerry Molitor's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jerry Molitor accept my insurance?

Dr. Jerry Molitor accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 612-626-6100 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Molitor's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 38 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile